March 23, 2012
168
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Oct. 22 (Bloomberg) -- Tony Butler, an analyst at Barclays Capital, talks with Bloomberg's Margaret Brennan about the outlook for pharmaceutical stocks.
Merck & Co., set to buy rival Schering-Plough Corp., said third-quarter profit tripled to $3.46 billion or $1.61 on the sale of its Merial animal health unit to Sanofi-Aventis SA. Bristol-Myers Squibb Co. said net income rose 64 percent to $966 million or 48 cents a share. Both companies reported earnings today. (Source: Bloomberg)
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.